Arming a replicating adenovirus with osteoprotegerin reduces the tumor burden in a murine model of osteolytic bone metastases of breast cancer.

MLA

Cody, J. J., et al. “Arming a Replicating Adenovirus with Osteoprotegerin Reduces the Tumor Burden in a Murine Model of Osteolytic Bone Metastases of Breast Cancer.” Cancer Gene Therapy, vol. 17, no. 12, Dec. 2010, p. 906. EBSCOhost, https://doi.org/10.1038/cgt.2010.60.

APA

Cody, J. J., Rivera, A. A., Lyons, G. R., Yang, S. W., Wang, M., Sarver, D. B., Wang, D., Selander, K. S., Kuo, H.-C., Meleth, S., Feng, X., Siegal, G. P., & Douglas, J. T. (2010). Arming a replicating adenovirus with osteoprotegerin reduces the tumor burden in a murine model of osteolytic bone metastases of breast cancer. Cancer Gene Therapy, 17(12), 906. https://doi.org/10.1038/cgt.2010.60

Chicago

Cody, J J, A A Rivera, G R Lyons, S W Yang, M Wang, D B Sarver, D Wang, et al. 2010. “Arming a Replicating Adenovirus with Osteoprotegerin Reduces the Tumor Burden in a Murine Model of Osteolytic Bone Metastases of Breast Cancer.” Cancer Gene Therapy 17 (12): 906. doi:10.1038/cgt.2010.60.